174 related articles for article (PubMed ID: 2568748)
1. Nonthrombolytic intervention in acute myocardial infarction.
Kirshenbaum JM
Am J Cardiol; 1989 Jul; 64(4):25B-28B. PubMed ID: 2568748
[TBL] [Abstract][Full Text] [Related]
2. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
3. Esmolol in acute ischemic syndromes.
Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
[TBL] [Abstract][Full Text] [Related]
4. The golden hours of the myocardial infarction: nonthrombolytic interventions.
Mitchell JM; Wheeler WS
Ann Emerg Med; 1991 May; 20(5):540-8. PubMed ID: 1673828
[TBL] [Abstract][Full Text] [Related]
5. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
[TBL] [Abstract][Full Text] [Related]
6. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
7. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
Hansen O; Johansson BW
J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
[TBL] [Abstract][Full Text] [Related]
8. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
Yusuf S
Chest; 1988 Jan; 93(1 Suppl):25S-28S. PubMed ID: 2891466
[No Abstract] [Full Text] [Related]
9. Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
Viray R; Turlapaty P; Laddu A
Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):153-61. PubMed ID: 2900818
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive medical therapy for acute myocardial infarction.
Mancuso GM; Vacek JL; Forker AD
Postgrad Med; 1994 Mar; 95(4):97-102, 109. PubMed ID: 7907177
[TBL] [Abstract][Full Text] [Related]
11. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
Raos V; Bergovec M
Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis.
Becker RC; Gore JM
Am J Cardiol; 1991 Jan; 67(3):25A-31A. PubMed ID: 1671315
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Acute MI. Institute for Clinical Systems Improvement.
Postgrad Med; 1999 Nov; 106(6):57-8, 62-4, 74-6; passim. PubMed ID: 10576003
[No Abstract] [Full Text] [Related]
14. Clinical outcome of acute myocardial infarction in patients on treatment with beta-blockers or calcium antagonists. A study of 7,922 hospitalized first myocardial infarctions.
Hansen O; Johansson BW; Gullberg B
Cardiology; 1992; 80(5-6):382-91. PubMed ID: 1360331
[TBL] [Abstract][Full Text] [Related]
15. Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction.
Daga MK; Chaudhary M; Sharma B; Bhattacharjee J; Ghambhir DS; Arora N; Sudha R
J Assoc Physicians India; 2003 Jul; 51():677-80. PubMed ID: 14621036
[TBL] [Abstract][Full Text] [Related]
16. The actions of talinolol, a beta 1-selective beta blocker, in cardiac arrhythmia and acute myocardial infarction.
Assmann I
Curr Med Res Opin; 1995; 13(6):325-42. PubMed ID: 8829891
[TBL] [Abstract][Full Text] [Related]
17. Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient.
Zaroslinski J; Borgman RJ; O'Donnell JP; Anderson WG; Erhardt PW; Kam ST; Reynolds RD; Lee RJ; Gorczynski RJ
Life Sci; 1982 Aug; 31(9):899-907. PubMed ID: 6129559
[TBL] [Abstract][Full Text] [Related]
18. [Esmolol in anesthesiology: pharmacology and indications].
Fita G; Gomar C; Rovira I
Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):404-14. PubMed ID: 10613078
[TBL] [Abstract][Full Text] [Related]
19. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Kloner RA; Kirshenbaum J; Lange R; Antman EM; Braunwald E
Am J Cardiol; 1985 Oct; 56(11):40F-48F. PubMed ID: 2864848
[TBL] [Abstract][Full Text] [Related]
20. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
